Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone - PubMed (original) (raw)
Clinical Trial
Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone
B Tönshoff et al. Eur J Endocrinol. 1995 Apr.
Abstract
We examined excretion of urinary insulin-like growth factors I and II (IGF-I and IGF-II) and their major binding protein IGFBP-3 in comparison to their respective serum concentration in nine healthy female volunteers (median age 25 years, range 22-27) under baseline conditions and after stimulation with recombinant human growth hormone (rhGH), 4.5 IU twice daily subcutaneously for a period of 3 days. The IGFs were measured in unconcentrated urine by use of recently developed, highly sensitive radioimmunoassays. The IGFBP-3 was measured by a specific radioimmunoassay. The mean (+/- SD) urinary concentrations of IGF-I (0.08 +/- 0.07 micrograms/l), IGF-II (1.02 +/- 0.47 micrograms/l) and IGFBP-3 (19.1 +/- 6.9 micrograms/l) were two to three orders of magnitude lower than in serum. The ratio of IGF-II over IGF-I concentration in urine (13:1) was five times higher than in serum (2.5:1), and the ratio of IGFBP-3 over the sum of IGF-I and IGF-II in urine (17:1) was four times higher than in serum (4:1). Urinary excretion was 63.3 +/- 46.6 ng.m-2.24h-1 for IGF-I, 1002 +/- 598 ng.m-2.24h-1 for IGF-II and 18039 +/- 4983 ng.m-2.24h-1 for IGFBP-3. Using fast protein liquid exclusion chromatography, only immunoreactive IGFBP-3 components of less than 60 kD were detected in urine, with a major peak at 20 kD. Urinary IGFBP-3 excretion correlated with serum IGFBP-3 (r = 0.61, p < 0.01) and the glomerular filtration rate (r = 0.56, p < 0.05) measured by steady-state inulin infusion clearances.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.
Gargosky SE, Hasegawa T, Tapanainen P, MacGillivray M, Hasegawa Y, Rosenfeld RG. Gargosky SE, et al. J Clin Endocrinol Metab. 1993 Jun;76(6):1631-7. doi: 10.1210/jcem.76.6.7684745. J Clin Endocrinol Metab. 1993. PMID: 7684745 - The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE, Wilson KF, Fielder PJ, Vaccarello MA, Guevara-Aguirre J, Diamond FB, Baxter RC, Rosenbloom AL, Rosenfeld RG. Gargosky SE, et al. J Clin Endocrinol Metab. 1993 Dec;77(6):1683-9. doi: 10.1210/jcem.77.6.7505289. J Clin Endocrinol Metab. 1993. PMID: 7505289 - Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
Bang P, Degerblad M, Thorén M, Schwander J, Blum W, Hall K. Bang P, et al. Acta Endocrinol (Copenh). 1993 May;128(5):397-404. Acta Endocrinol (Copenh). 1993. PMID: 7686320 - Insulin-like growth factors and their binding proteins: review of functions and clinical applications.
Yeoh SI. Yeoh SI. Ann Acad Med Singap. 1990 Jul;19(4):497-500. Ann Acad Med Singap. 1990. PMID: 1699469 Review. - Screening tests for growth hormone deficiency.
Evans AJ. Evans AJ. J R Soc Med. 1995 Mar;88(3):161P-165P. J R Soc Med. 1995. PMID: 7538588 Free PMC article. Review. No abstract available.
Cited by
- The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins.
Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. Adachi J, et al. Genome Biol. 2006;7(9):R80. doi: 10.1186/gb-2006-7-9-R80. Genome Biol. 2006. PMID: 16948836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous